This bill amends RSA 318-B:9 to allow pharmacists to administer certain long-acting controlled drugs in addition to their existing authority to sell and dispense these medications. The new legal language includes provisions that enable pharmacists to administer controlled drugs pursuant to a prescription, thereby expanding their role in patient care. Specifically, the bill inserts language that allows for the administration of controlled drugs and clarifies that pharmacists can be reimbursed for these administration services in addition to the reimbursement for the drugs themselves.

Additionally, the bill removes the phrase "and" from certain sections, streamlining the language regarding the sale, dispensing, and now administration of controlled drugs. The changes aim to enhance the accessibility of long-acting injectable medications by allowing pharmacists to play a more active role in their administration, which could improve patient outcomes and streamline healthcare delivery. The act is set to take effect 60 days after its passage, on August 23, 2025.

Statutes affected:
Introduced: 318-B:9
As Amended by the Senate: 318-B:9
Version adopted by both bodies: 318-B:9
CHAPTERED FINAL VERSION: 318-B:9